atai Life Sciences N.V (ATAI) PT Raised to $14 at Canaccord Genuity, 'significantly undervalued'

October 22, 2025 6:23 AM EDT Send to a Friend
Canaccord Genuity analyst Sumant Kulkami raised the price target on atai Life Sciences N.V (NASDAQ: ATAI) to $14.00 (from $11.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login